The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection

被引：0
|
作者：
Van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Bethesda Hosp, Hoogeven, Netherlands
来源：
GUT | 1998年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [31] Ranitidine bismuth citrate (RBC) or omeprazole (O) with clarithromycin (C) and amoxycillin (A) for one week in the eradication of H-pylori
    Cabooter, M
    Dekkers, CPM
    Theodors, A
    Vanweerts, S
    GASTROENTEROLOGY, 1999, 116 (04) : A345 - A345
  • [32] Pantoprazole vs. ranitidine bismuth citrate plus two antibiotics for H-pylori eradication
    Gisbert, JP
    Marcos, S
    Gisbert, JL
    Carpio, D
    Valle, J
    Cabrera, MM
    Cruzado, AI
    Garcia-Gravalos, R
    Pajares, JM
    GASTROENTEROLOGY, 1999, 116 (04) : A172 - A172
  • [33] Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection
    Savarino, V
    Zentilin, P
    Bisso, G
    Pivari, M
    Bilardi, C
    Biagini, R
    Mele, MR
    Mansi, C
    Termini, R
    Vigneri, S
    Celle, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (01) : 43 - 47
  • [34] Ranitidine bismuth citrate (RBC) plus amoxycillin and tinidazole as second-line therapy for H.pylori infection after failure of the standard "Maastricht triple therapy"
    Perri, F
    Villani, MR
    Annese, V
    Quitadamo, M
    Niro, GA
    Mangia, A
    Andriulli, A
    GASTROENTEROLOGY, 2001, 120 (05) : A581 - A581
  • [35] Pantoprazole vs. ranitidine bismuth citrate plus two antibiotics for H-pylori eradication
    Gisbert, JP
    Carpio, D
    Marcos, S
    Gisbert, JL
    Cabrera, MM
    Cruzado, AI
    Grávalos, RG
    Pajares, JM
    GUT, 1999, 45 : A108 - A109
  • [36] Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H-pylori infection
    Jaup, BH
    Norrby, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) : 275 - 277
  • [37] A comparison of ranitidine bismuth citrate-clarithromycin (RBC-C) dual therapy vs. omeprazole, clarithromycin, amoxycillin (OCA) triple therapy given for 7 days in the treatment of H-pylori infection
    van Zanten, SJOV
    Chiba, N
    Barkun, AN
    Fallone, CA
    Farley, A
    Cockeram, A
    Dallaire, C
    Simms, L
    Nicholls, B
    GASTROENTEROLOGY, 2001, 120 (05) : A586 - A586
  • [38] Ranitidine bismuth citrate (RBC) and azithromycin (Az) based therapy for Helicobacter pylori infection in peptic ulcer patients
    Duvnjak, M
    Vucelic, B
    Katicic, M
    Krizman, I
    Culig, J
    Pavic-Sladoljev, D
    Naletilic, D
    GUT, 1999, 45 : A118 - A118
  • [39] Ranitidine bismuth citrate (RBC) is more effective than omeprazole in the eradication of H-pylori when co-prescribed with clarithromycin
    Pare, P
    Romaozinho, J
    Bardhan, KD
    French, PC
    Roberts, PM
    GASTROENTEROLOGY, 1997, 112 (04) : A251 - A251
  • [40] Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection
    Mönkemüller, KE
    Hirschowitz, BI
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (05) : 661 - 665
12345